Nanosonics Ltd (ASX: NAN) Share Price and News

Dr McIntyre executive background is in strategy, particularly in the areas of medical technology and healthcare, with many years as a partner at L.E.K. Consulting in the US and Australia, where she led the Asia Pacific Health practice. She is also member of the Risk committee and Chair of Innovation and Development Committee.

Dr Marshall is a technology innovator, physicist, and business leader. During his 26 years in the United States, Dr Marshall co-founded six companies in a range of markets including medical device which went public. Over the past 30 years, he has served as CEO/MD of six companies, and Chairman of four. He was MD, then co-Chairman of Arasor which he took public in 2006. He is also member of the Innovation and Development Committee.

Mr Kavanagh has more than 29 years of international commercial experience in the healthcare market, having held local, regional and global roles in medical device and pharmaceutical industries. Before joining Nanosonics, he was Senior Vice President of Global Marketing for the medical device company Cochlear Ltd, a position he held for more than 10 years.

Ms McDonald has background in corporate and commercial law, having practised for many years as a partner at Ashurst. Ms McDonald was Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012 to 2013) and was a member of the Australian Takeovers Panel from 2001 to 2010. She is also member of the Innovation and Development Committee.

Mr Sargent's career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. Mr Sargent has been a Non-Executive Director of Origin Energy Limited and is also a Non-Executive Director of Ramsay Healthcare Limited (since December 2021). He is also member of the Risk and Innovation and Development Committee.

Dr Batten brings over 30 years of experience in the healthcare sector gained in non-executive and executive roles, and medical practitioner and clinical roles. Dr Batten was CEO of Imperial College Healthcare NHS Trust in the UK, St Vincent's Health Australia, Eastern Health and Dental Health Services Victoria. She is also member of the Risk Committee and Innovation and Development Committee.

Mr Dalbosco brings experience to the Company. He had a executive career, at EY, where he held a number of senior leadership roles spanning multiple regions and functions, including Oceania Managing Partner and CEO, Asia Pacific Joint Deputy CEO, and Oceania Managing Partner Transaction Advisory Services. Prior to these roles, he was in advising clients across a range of industries, on mergers and acquisitions, financial due diligence, and commercial strategy. Beyond his corporate career, Gerard has governance experience. He is currently a Director at Medibank Private Ltd (ASX:MPL) and serves as Chair of Melbourne Archdiocese Catholic Schools. He is also Chair of the Gillespie Family Council & Gillespie Family Foundation (founders/owners of Bakers Delight). Previous governance roles include Mercy Health & Aged Care (Director and Chair of Finance and Audit Committee), Berry Street Victoria (Director and Member of Finance Committee) and the Committee for Melbourne (Director, Deputy Chair and Chair of Finance, Audit and Risk).

-

-

-

-

-

-

-

-

-

-